What is ADMA Biologics's investing cash flow?

ADMA Biologics (ADMA) reported investing cash flow of $2.4M in Q1 2026.

How has ADMA Biologics's investing cash flow changed year-over-year?

ADMA Biologics's investing cash flow increased by 150.9% year-over-year, from -$4.72M to $2.4M.

What is the long-term trend for ADMA Biologics's investing cash flow?

Over 4 years (2021 to 2025), ADMA Biologics's investing cash flow has grown at a 12.8% compound annual growth rate (CAGR), from -$13.51M to -$21.89M.

What does investing cash flow mean?

Total net cash provided by or used in investing activities — capex, acquisitions, investment purchases/sales, and other investing items.

ADMA Biologics ADMA Investing Cash Flow

Investing Cash Flow at other companies

AbCellera Biologics Inc.ABCL

-$25.08M-416%

AnaptysBio, Inc.ANAB

$34.98M+136%

ZymeworksZYME

$69.96M+474%

Bio-Rad LaboratoriesBIO

-$93.2M-3,314%

Apogee Therapeutics, Inc.APGE

-$35.35M-372%

Quest DiagnosticsDGX

-$152M-32.2%

Other financials

Income statement

See full

Revenue$114.5M-0.3%

Gross profit$80.8M+32.2%

Operating income$58.3M+67.1%

Net income$45.3M+68.5%

EPS (diluted)$0.19+72.7%

Balance sheet

See full

Cash & equivalents$138.2M+92.9%

Total debt$204.4M+2,055%

Total equity$390.3M+4.5%

Total assets$665.2M+30.3%

Cash flow

See full

Operating cash flow$58.2M+396%

CapEx$2.5M-45.9%

Free cash flow$55.7M+329%

Valuation

See full

Market cap$2.01B-54.5%

Enterprise value$2.08B-52.5%

P/E12.2×-9.2×

P/S4×-5.7×

Profitability

See full

Gross margin61.3%+8.7pp

Operating margin42.1%+9.0pp

Net margin32.4%-12.6pp

FCF margin21.2%+1.4pp

Returns & leverage

See full

Return on equity43.3%-35.2pp

Debt / equity0.5×+0.5×

Current ratio7×+0.4×

Where this comes from

Reported directly by ADMA Biologics in its filing.

Tagged under the XBRL concept us-gaap:NetCashProvidedByUsedInInvestingActivities.

The official record: ADMA Biologics’s 10-Q, filed May 6, 2026, on SEC EDGAR. View the filing →

Ask your AI about ADMA Biologics's investing cash flow.

Connect your AI assistant and compare it to peers, right in your chat.

Connect your AI

Claude

Questions, answered.

What is ADMA Biologics's investing cash flow?: ADMA Biologics (ADMA) reported investing cash flow of $2.4M in Q1 2026.
How has ADMA Biologics's investing cash flow changed year-over-year?: ADMA Biologics's investing cash flow increased by 150.9% year-over-year, from -$4.72M to $2.4M.
What is the long-term trend for ADMA Biologics's investing cash flow?: Over 4 years (2021 to 2025), ADMA Biologics's investing cash flow has grown at a 12.8% compound annual growth rate (CAGR), from -$13.51M to -$21.89M.
What does investing cash flow mean?: Total net cash provided by or used in investing activities — capex, acquisitions, investment purchases/sales, and other investing items.